Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Lymphoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Bevacizumab 26Cetuximab 24Fluorouracil 23Leucovorin 22Oxaliplatin 19pembrolizumab 18Specimen Handling 11Irinotecan 10Nivolumab 8Magnetic Resonance Spectroscopy 8atezolizumab 7Biopsy 7Pemetrexed 6Panitumumab 6Cisplatin 6Carboplatin 6trifluridine tipiracil drug combination 5fludarabine 5encorafenib 5HMPL-013 5Gemcitabine 5Folfox protocol 5Standard of Care 4Immunoglobulin G 4Disulfides 4Cyclophosphamide 4zanidatamab 3regorafenib 3fludarabine phosphate 3dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms × balstilimab × 30 days × Clear all
NCT05571293 2026-05-22

NEST-1

Weill Medical College of Cornell University

Phase 2 Active not recruiting
26 enrolled 15 charts
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡